We are Sorry, This Page doesn't Exist

Johnson & Johnson (NYSE: JNJ) stock was on the rise Wednesday following better-than-expected third-quarter earnings and guidance, but analysts are mostly leery of boosting recommendati.....»»

Johnson & Johnson (NYSE: JNJ) stock was on the rise Wednesday following better-than-expected third-quarter earnings and guidance, but analysts are mostly leery of boosting recommendations in light of a string of legal ch.....»»

On CNBC's "Fast Money Final Trade," Tim Seymour said that $120 is a very good stop for Johnson & Johnson (NYSE: JNJ). He is a buyer of the stock. read more.....»»

Is Johnson Controls International plc (NYSE:JCI) a worthy investment now? The best stock pickers are getting more optimistic. The number of.....»»

Johnson & Johnson (NYSE:JNJ) Stock Oversold Overall, the bias in prices is: Downwards.   The projected upper bound is: 133.19. The projected lower bound is: 121.74. The projected closing p.....»»

Johnson & Johnson (NYSE:JNJ) Heffx Stock Technicals Overall, the bias in prices is: Downwards. The projected upper bound is: 128.77. The projected lower bound is: 118.72. The projected closing price is: 123.75......»»

Johnson & Johnson (NYSE:JNJ) Stock Worth Watching Overall, the bias in prices is: Downwards. Note: this chart shows extraordinary price action to the downside. By the way, prices are vulnerable to a correct.....»»

Johnson & Johnson (NYSE: JNJ) stock tanked more than 11 percent Friday morning after an investigative piece by Reuters alleges the company knew one of its most popular products was dangerous for decades. read more.....»»

Johnson Controls International plc plans to use nearly all of the proceeds of the sale of its Power Solutions business for debt repayment and stock buybacks, its CEO confirmed Friday. Johnson Controls (NYSE:JCI) announced the sale of Power Solution.....»»

Auris Medical Holding AG (NASDAQ: EARS) stock traded higher by as much as 30 percent Wednesday morning after Johnson & Johnson (NYSE: JNJ) announced a $3.4 billion buyout of Auris Health. The only problem? read more.....»»

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported first-quarter adjusted EPS of $2.71, up 12.4% year over year, beat.....»»

Johnson & Johnson (NYSE: JNJ) is set to release earnings results for its first quarter before the opening bell on April 16, 2024. Latest Ratings for J.....»»

Gordon Johnson, CEO of GLJ Research, reconfirmed his bearish outlook on Tesla Inc (NASDAQ: TSLA) Monday on CNBC's "Squawk Box." Latest Rat.....»»

Roughly 57% of investor votes cast backed healthcare company Johnson & Johnson (NYSE:JNJ)'s executive pay for 2020, a low level of support for a proposal most shareholders usually rubberstamp......»»

The CEO of Emergent BioSolutions, the government contractor that destroyed 15 million doses of Johnson & Johnson's COVID-19 vaccine, sold more than $10 million worth of his stock in the company before its share prices plummeted......»»

Johnson & Johnson (NYSE: JNJ) said Tuesday that the European rollout of its COVID-19 vaccine is set to continue after it got the go-ahead from the regulator on the continent. read more.....»»

White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on administering the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine and get the vaccine “back on track.” read more.....»»

The S&P 500 finished at a record and technol.....»»

Gordon Johnson, the CEO of GLJ Research, says Tesla's 2% sequential growth is hardly "transformational" amid price cuts and increasing sales. Tesla head .....»»

Shares of Emergent BioSolutions Inc. were down 6.8% in premarket trading on Thursday, the day after Johnson & Johnson confirmed that a batch of its COVID-19 vaccines manufactured at an Emergent plant did not meet "quality standards." Th.....»»